New drugs for the treatment of diabetes mellitus - Part I: Thiazolidinediones and their evolving cardiovascular implications

被引：90

作者：

McGuire, Darren K. ^{[1
,2
]}

Inzucchi, Silvio E. ^{[3
]}

机构：

[1] Univ Texas Dallas, SW Med Ctr, Div Cardiol, Dallas, TX 75235 USA

[2] Univ Texas Dallas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75235 USA

[3] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA

来源：

CIRCULATION | 2008年 / 117卷 / 03期

关键词：

cardiovascular diseases; diabetes mellitus; drugs; glucose; thiazolidinediones;

D O I：

10.1161/CIRCULATIONAHA.107.704080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：440 / 449

页数：10

共 90 条

[1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].

Adams, M ;

Montague, CT ;

Prins, JB ;

Holder, JC ;

Smith, SA ;

Sanders, L ;

Digby, JE ;

Sewter, CP ;

Lazar, MA ;

Chatterjee, VKK ;

O'Rahilly, S .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153

[2]

[Anonymous], 2007, DIABETES CARE, DOI DOI 10.2337/DC07-S004

[3] Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J].

Aronoff, S ;

Rosenblatt, S ;

Braithwaite, S ;

Egan, JW ;

Mathisen, AL ;

Schneider, RL .

DIABETES CARE, 2000, 23 (11) :1605-1611

[4] Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo [J].

Asakawa, M ;

Takano, H ;

Nagai, T ;

Uozumi, H ;

Hasegawa, H ;

Kubota, N ;

Saito, T ;

Masuda, Y ;

Kadowaki, T ;

Komuro, I .

CIRCULATION, 2002, 105 (10) :1240-1246

[5]

Berhanu Paulos, 2006, Diab Vasc Dis Res, V3, P39, DOI 10.3132/dvdr.2006.005

[6] Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial [J].

Brooks, Maria Mori ;

Frye, Robert L. ;

Genuth, Saul ;

Detre, Katherine M. ;

Nesto, Richard ;

Sobel, Burton E. ;

Kelsey, Sheryl F. ;

Orchard, Trevor J. .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (12A) :9G-19G

[7] Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association [J].

Buse, John B. ;

Ginsberg, Henry N. ;

Bakris, George L. ;

Clark, Nathaniel G. ;

Costa, Fernando ;

Eckel, Robert ;

Fonseca, Vivian ;

Gerstein, Hertzel C. ;

Grundy, Scott ;

Nesto, Richard W. ;

Pignone, Michael P. ;

Plutzky, Jorge ;

Porte, Daniel ;

Redberg, Rita ;

Stitzel, Kimberly F. ;

Stone, Neil J. .

DIABETES CARE, 2007, 30 (01) :162-172

[8] The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: A placebo-controlled randomized clinical trial [J].

Caballero, AE ;

Saouaf, R ;

Lim, SC ;

Hamdy, O ;

Abou-Elenin, K ;

O'Connor, C ;

LoGerfo, FW ;

Horton, ES ;

Veves, A .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (02) :173-180

[9] A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors [J].

Chiquette, E ;

Ramirez, G ;

DeFronzo, R .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (19) :2097-2104

[10] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

← 1 2 3 4 5 6 7 8 9 →